Table 3.
Relationship between PGM5‐AS1 expression and the clinical indicators of osteosarcoma patients. TNM, tumor–node–metastasis.
| Clinicopathologic features | Cases (n) | PGM5‐AS1 expression | P‐value | |
|---|---|---|---|---|
| Low (n = 36) | High (n = 37) | |||
| Age (years) | ||||
| ≤ 20 | 33 | 18 | 15 | 0.484 |
| > 20 | 40 | 18 | 22 | |
| Gender | ||||
| Male | 41 | 23 | 18 | 0.241 |
| Female | 32 | 13 | 19 | |
| TNM stage | ||||
| I + II | 48 | 30 | 18 | 0.003 |
| III + IV | 25 | 6 | 19 | |
| Distant metastasis | ||||
| Yes | 25 | 7 | 18 | 0.013 |
| No | 48 | 29 | 19 | |
| Tumor grade | ||||
| Low | 41 | 25 | 16 | 0.034 |
| High | 32 | 11 | 21 | |
| Tumor size | ||||
| ≤ 5cm | 38 | 26 | 12 | 0.001 |
| > 5cm | 35 | 10 | 25 | |